{"transactions":[{"id":1772418,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-28T21:30:09.000Z","date":"2023-09-26","kind":"sale","planned":false,"acquired":false,"shares":6000000,"price":0.5,"value":3000000.0,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":17652466,"source":{"system":"sec-edgar","filing":"0000899243-23-019611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000089924323019611/doc4.xml","form_type":"4"}},{"id":2170341,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-31T23:03:34.000Z","date":"2022-08-30","kind":"sale","acquired":false,"shares":100000,"price":5.2652,"value":526520.0,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1235 to $5.49, inclusive. The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":23652466,"source":{"system":"sec-edgar","filing":"0000899243-22-030136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000089924322030136/doc4.xml","form_type":"4"}},{"id":2170340,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-31T23:03:34.000Z","date":"2022-08-29","kind":"sale","acquired":false,"shares":400000,"price":5.3268,"value":2130720.0,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.205 to $5.475, inclusive. The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":23752466,"source":{"system":"sec-edgar","filing":"0000899243-22-030136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000089924322030136/doc4.xml","form_type":"4"}},{"id":2456520,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-30T22:12:27.000Z","date":"2021-12-28","kind":"sale","acquired":false,"shares":2764,"price":8.5101,"value":23521.9164,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.50 to $8.53, inclusive.  The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":24152466,"source":{"system":"sec-edgar","filing":"0000875045-21-000061","document":"wf-form4_164090233143707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504521000061/wf-form4_164090233143707.xml","form_type":"4"}},{"id":2458127,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T13:11:20.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":600,"price":8.56,"value":5136.0,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":24155230,"source":{"system":"sec-edgar","filing":"0000875045-21-000060","document":"wf-form4_164069706538898.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504521000060/wf-form4_164069706538898.xml","form_type":"4"}},{"id":2458126,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T13:11:20.000Z","date":"2021-12-23","kind":"sale","acquired":false,"shares":81187,"price":8.5547,"value":694530.4289,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.50 to $8.65, inclusive.  The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":24155830,"source":{"system":"sec-edgar","filing":"0000875045-21-000060","document":"wf-form4_164069706538898.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504521000060/wf-form4_164069706538898.xml","form_type":"4"}},{"id":2477884,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-10T21:08:31.000Z","date":"2021-12-09","kind":"sale","acquired":false,"shares":23660,"price":8.5605,"value":202541.43,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.50 to $8.71, inclusive.  The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":24237017,"source":{"system":"sec-edgar","filing":"0000875045-21-000059","document":"wf-form4_163917049537863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504521000059/wf-form4_163917049537863.xml","form_type":"4"}},{"id":2479729,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-09T21:08:53.000Z","date":"2021-12-08","kind":"sale","acquired":false,"shares":75814,"price":8.6373,"value":654828.2622,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.50 to $8.735, inclusive.  The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":24260677,"source":{"system":"sec-edgar","filing":"0000875045-21-000058","document":"wf-form4_163908412073554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504521000058/wf-form4_163908412073554.xml","form_type":"4"}},{"id":2479728,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-09T21:08:53.000Z","date":"2021-12-07","kind":"sale","acquired":false,"shares":52178,"price":8.5177,"value":444436.5506,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.50 to $8.595, inclusive.  The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":24336491,"source":{"system":"sec-edgar","filing":"0000875045-21-000058","document":"wf-form4_163908412073554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504521000058/wf-form4_163908412073554.xml","form_type":"4"}},{"id":2487222,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-03T21:09:21.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":1874,"price":8.5074,"value":15942.8676,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.50 to $8.515, inclusive.  The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":24388669,"source":{"system":"sec-edgar","filing":"0000875045-21-000057","document":"wf-form4_163856574488863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504521000057/wf-form4_163856574488863.xml","form_type":"4"}},{"id":2487221,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-03T21:09:21.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":730,"price":8.5249,"value":6223.177,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.50 to $8.54, inclusive.  The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":24390543,"source":{"system":"sec-edgar","filing":"0000875045-21-000057","document":"wf-form4_163856574488863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504521000057/wf-form4_163856574488863.xml","form_type":"4"}},{"id":2492534,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109386,"kind":"organization","name":"Biogen MA Inc.","position":2,"cik":"0001810387","reported_name":"Biogen MA Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T21:20:45.000Z","date":"2021-11-26","kind":"sale","acquired":false,"shares":28884,"price":8.6011,"value":248434.1724,"ownership":{"direct":false,"nature":"By Biogen MA Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $8.50 to $8.74, inclusive.  The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc."}],"balance_after":24391273,"source":{"system":"sec-edgar","filing":"0000875045-21-000055","document":"wf-form4_163830723294834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504521000055/wf-form4_163830723294834.xml","form_type":"4"}},{"id":4474246,"issuer":{"id":168487,"kind":"organization","name":"Bioverativ Inc.","symbol":"BIVV"},"owners":[{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB","position":1,"cik":"0000875045","reported_name":"BIOGEN INC.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2017-02-01T22:21:48.000Z","date":"2017-02-01","kind":"other","acquired":false,"shares":107975968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Biogen Inc. distributed the shares to its shareholders on a pro rata basis in connection with the separation of the Issuer from Biogen Inc. on February 1, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 31, 2017, the 1,000 shares of common stock of the Issuer, issued and outstanding as of such date, were reclassified and subdivided into 107,975,968 shares resulting in the reporting person's ownership of a total of 107,975,968 shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-17-003387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217003387/form4.xml","form_type":"4"}}]}